Jounce Therapeutics Reports Third Quarter 2020 Financial Results
November 06, 2020 07:00 ET
|
Jounce Therapeutics, Inc.
-On track to begin enrollment in the Phase 1 trial for JTX-8064 by year-end 2020- -Established exclusive license agreement with Gilead for JTX-1811- -Initiated the Phase 2 SELECT...
ATEC Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
November 05, 2020 16:05 ET
|
Alphatec Holdings, Inc.
U.S. Revenue Grows 43%Eighth Consecutive Quarter of Double-Digit Revenue Growth CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq:...
Playa Hotels & Resorts N.V. Reports Third Quarter 2020 Results
November 04, 2020 16:05 ET
|
Playa Hotels & Resorts N.V.
FAIRFAX, Va., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Playa Hotels & Resorts N.V. (the “Company” or “Playa”) (NASDAQ: PLYA) today announced results of operations for the three and nine months ended...
Jounce Therapeutics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Friday, November 6, 2020
October 30, 2020 08:00 ET
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
Piedmont Office Realty Trust Reports Third Quarter 2020 Results
October 29, 2020 16:15 ET
|
Piedmont Office Realty Trust, Inc.
Atlanta, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust, Inc. ("Piedmont" or the "Company") (NYSE:PDM), an owner of Class A office properties located primarily in select sub-markets...
ATEC Announces Preliminary Third Quarter 2020 Financial Results
October 07, 2020 16:53 ET
|
Alphatec Holdings, Inc.
Third quarter U.S. revenue expected to grow over 40%Eighth consecutive quarter of double-digit revenue growthRevenue per case expands on strong pull- through from SafeOp neuromonitoring and new...